Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Rheumatoid Arthritis

  Free Subscription


Articles published in Clin Exp Immunol

Retrieve available abstracts of 47 articles:
HTML format
Text format



Single Articles


    November 2017
  1. XU L, Hu F, Zhu H, Liu X, et al
    Soluble TAM receptor tyrosine kinases in rheumatoid arthritis: Correlation with disease activity and bone destruction.
    Clin Exp Immunol. 2017 Nov 17. doi: 10.1111/cei.13082.
    PubMed     Text format     Abstract available


  2. LI J, Xu B, Wu C, Yan X, et al
    TXNDC5 Contributes to Rheumatoid Arthritis by Down-regulating IGFBP1 Expression.
    Clin Exp Immunol. 2017 Nov 13. doi: 10.1111/cei.13080.
    PubMed     Text format     Abstract available


    October 2017
  3. EBE H, Matsumoto I, Kawaguchi H, Kurata I, et al
    Clinical and functional significance of STEAP4-splice variant in CD14+ monocytes in patients with rheumatoid arthritis.
    Clin Exp Immunol. 2017 Oct 28. doi: 10.1111/cei.13076.
    PubMed     Text format     Abstract available


  4. TAKAHASHI H, Tsuboi H, Asashima H, Hirota T, et al
    cDNA microarray analysis identifies NR4A2 as a novel molecule involved in the pathogenesis of Sjogren's syndrome.
    Clin Exp Immunol. 2017;190:96-109.
    PubMed     Text format     Abstract available


  5. ZHANG S, Huang G, Yuan K, Zhu Q, et al
    Tanshinone IIA ameliorates chronic arthritis in mice by modulating neutrophil activities.
    Clin Exp Immunol. 2017;190:29-39.
    PubMed     Text format     Abstract available


    September 2017
  6. RODRIGUEZ PC, Prada DM, Moreno E, Aira LE, et al
    The anti-CD6 antibody itolizumab provides clinical benefit without lymphopenia in rheumatoid arthritis patients: results from a 6-month, open-label phase I clinical trial.
    Clin Exp Immunol. 2017 Sep 30. doi: 10.1111/cei.13061.
    PubMed     Text format     Abstract available


    August 2017
  7. TANG Y, Wang B, Sun X, Li H, et al
    Rheumatoid arthritis fibroblast-like synoviocytes cocultured with PBMC increased peripheral CD4+CXCR5+ICOS+ T cells numbers.
    Clin Exp Immunol. 2017 Aug 18. doi: 10.1111/cei.13025.
    PubMed     Text format     Abstract available


  8. BECERRA E, De La Torre I, Leandro MJ, Cambridge G, et al
    B cell phenotypes in patients with rheumatoid arthritis relapsing after Rituximab: Expression of B cell activating factor-binding receptors on B cell subsets.
    Clin Exp Immunol. 2017 Aug 11. doi: 10.1111/cei.13024.
    PubMed     Text format     Abstract available


    July 2017
  9. WEHMEYER C, Pap T, Buckley CD, Naylor AJ, et al
    The role of stromal cells in inflammatory bone loss.
    Clin Exp Immunol. 2017;189:1-11.
    PubMed     Text format     Abstract available


  10. MAMELI G, Erre GL, Caggiu E, Mura S, et al
    Identification of a HERV-K env surface peptide highly recognized in Rheumatoid Arthritis (RA) patients: a cross-sectional case-control study.
    Clin Exp Immunol. 2017;189:127-131.
    PubMed     Text format     Abstract available


    June 2017
  11. BOMMARITO D, Hall C, Taams LS, Corrigall VM, et al
    Inflammatory cytokines compromise programmed cell death-1 (PD-1)-mediated T cell suppression in inflammatory arthritis through up-regulation of soluble PD-1.
    Clin Exp Immunol. 2017;188:455-466.
    PubMed     Text format     Abstract available


  12. SCHAPER F, de Leeuw K, Horst G, Maas F, et al
    Autoantibodies to box A of high mobility group box 1 in systemic lupus erythematosus.
    Clin Exp Immunol. 2017;188:412-419.
    PubMed     Text format     Abstract available


    May 2017
  13. STUMER J, Biermann MHC, Knopf J, Magorivska I, et al
    Altered glycan accessibility on native immunoglobulin G complexes in early rheumatoid arthritis and its changes during therapy.
    Clin Exp Immunol. 2017 May 16. doi: 10.1111/cei.12987.
    PubMed     Text format     Abstract available


  14. WILLIS VC, Banda NK, Cordova KN, Chandra PE, et al
    Protein arginine deiminase 4 inhibition is sufficient for the amelioration of collagen-induced arthritis.
    Clin Exp Immunol. 2017;188:263-274.
    PubMed     Text format     Abstract available


  15. AGGARWAL A, Gupta R, Negi VS, Rajasekhar L, et al
    Urinary haptoglobin, alpha-1 anti-chymotrypsin and retinol binding protein identified by proteomics as potential biomarkers for lupus nephritis.
    Clin Exp Immunol. 2017;188:254-262.
    PubMed     Text format     Abstract available


    April 2017
  16. MITCHELL TS, Moots RJ, Wright HL
    JAK inhibitors prevent migration of rheumatoid arthritis neutrophils towards interleukin-8, but do not inhibit priming of the respiratory burst or ROS production.
    Clin Exp Immunol. 2017 Apr 2. doi: 10.1111/cei.12970.
    PubMed     Text format     Abstract available


  17. SCHINNERLING K, Aguillon JC, Catalan D, Soto L, et al
    The role of IL-6 signaling and its therapeutic blockage in skewing the T cell balance in rheumatoid arthritis.
    Clin Exp Immunol. 2017 Apr 1. doi: 10.1111/cei.12966.
    PubMed     Text format     Abstract available


  18. CONTRERAS RUIZ L, Mir FA, Turpie B, Masli S, et al
    Thrombospondin-derived peptide attenuates Sjogren's syndrome-associated ocular surface inflammation in mice.
    Clin Exp Immunol. 2017;188:86-95.
    PubMed     Text format     Abstract available


    February 2017
  19. VERHOEVEN F, Totoson P, Maguin-Gate K, Prigent-Tessier A, et al
    Glucocorticoids Improve Endothelial Function in Rheumatoid Arthritis: A Study in Rats with Adjuvant-induced Arthritis.
    Clin Exp Immunol. 2017 Feb 2. doi: 10.1111/cei.12938.
    PubMed     Text format     Abstract available


  20. TAHARA M, Tsuboi H, Segawa S, Asashima H, et al
    RORgammat antagonist suppresses M3 muscarinic acetylcholine receptor-induced Sjogren's syndrome-like sialadenitis.
    Clin Exp Immunol. 2017;187:213-224.
    PubMed     Text format     Abstract available


    December 2016
  21. APOSTOLOU E, Kapsogeorgou EK, Konsta OD, Giotakis I, et al
    Expression of type III interferons (IFNlambdas) and their receptor in Sjogren's syndrome.
    Clin Exp Immunol. 2016;186:304-312.
    PubMed     Text format     Abstract available


    November 2016
  22. LAI NS, Koo M, Yu CL, Lu MC, et al
    Immunopathogenesis of systemic lupus erythematosus and rheumatoid arthritis: The role of aberrant expression of non-coding RNAs in T cells.
    Clin Exp Immunol. 2016 Nov 23. doi: 10.1111/cei.12903.
    PubMed     Text format     Abstract available


  23. MARTINSSON K, Johansson A, Kastbom A, Skogh T, et al
    IgG1 and IgG4 anti-CCP associate with shared epitope, whereas IgG2 anti-CCP associates with smoking in patients with recent-onset rheumatoid arthritis (the Swedish TIRA project).
    Clin Exp Immunol. 2016 Nov 17. doi: 10.1111/cei.12901.
    PubMed     Text format     Abstract available


    October 2016
  24. MARIASELVAM CM, Tamouza R, Krishnamoorthy R, Charron D, et al
    Association of NKG2D gene variants with susceptibility and severity of Rheumatoid Arthritis.
    Clin Exp Immunol. 2016 Oct 26. doi: 10.1111/cei.12891.
    PubMed     Text format     Abstract available


  25. RUSCITTI P, Cipriani P, Ciccia F, Di Benedetto P, et al
    H-ferritin and CD68(+) /H-ferritin(+) monocytes/macrophages are increased in the skin of adult-onset Still's disease patients and correlate with the multi-visceral involvement of the disease.
    Clin Exp Immunol. 2016;186:30-8.
    PubMed     Text format     Abstract available


  26. PAN ZJ, Horton CG, Lawrence C, Farris AD, et al
    Plasmacytoid dendritic cells and type 1 interferon promote peripheral expansion of forkhead box protein 3(+) regulatory T cells specific for the ubiquitous RNA-binding nuclear antigen La/Sjogren's syndrome (SS)-B.
    Clin Exp Immunol. 2016;186:18-29.
    PubMed     Text format     Abstract available


    September 2016
  27. ANDERSON AE, Swan DJ, Wong OY, Buck M, et al
    Tolerogenic dendritic cells generated with dexamethasone and vitamin D3 regulate rheumatoid arthritis CD4+ T-cells partly via TGF-beta1.
    Clin Exp Immunol. 2016 Sep 26. doi: 10.1111/cei.12870.
    PubMed     Text format     Abstract available


    August 2016
  28. EDAVALATH S, Singh A, Soni N, Mohindra N, et al
    Peripheral blood Th17 frequency shows an inverse correlation with disease activity and MRI based osteitis and erosions in DMARD and Steroid naive established rheumatoid arthritis.
    Clin Exp Immunol. 2016 Aug 29. doi: 10.1111/cei.12860.
    PubMed     Text format     Abstract available


  29. CICCIA F, Guggino G, Ferrante A, Cipriani P, et al
    Interleukin-9 and T helper type 9 cells in rheumatic diseases.
    Clin Exp Immunol. 2016;185:125-32.
    PubMed     Text format     Abstract available


    July 2016
  30. YAMAKAWA M, Ouhara K, Kajiya M, Munenaga S, et al
    Porphyromonas gingivalis infection exacerbates the onset of rheumatoid arthritis in SKG mice.
    Clin Exp Immunol. 2016 Jul 27. doi: 10.1111/cei.12847.
    PubMed     Text format     Abstract available


  31. SZITTNER Z, Bentlage AE, Rovero P, Migliorini P, et al
    Label-free detection of immune complexes with myeloid cells.
    Clin Exp Immunol. 2016;185:72-80.
    PubMed     Text format     Abstract available


    June 2016
  32. CICCACCI C, Conigliaro P, Perricone C, Rufini S, et al
    Polymorphisms in STAT4, IL10, PSORS1C1, PTPN2 and MIR146A genes are differently associated with prognostic factors in Italian patients affected by Rheumatoid Arthritis.
    Clin Exp Immunol. 2016 Jun 24. doi: 10.1111/cei.12831.
    PubMed     Text format     Abstract available


  33. DE SANTIS M, Ceribelli A, Cavaciocchi F, Generali E, et al
    Effects of type II collagen epitope carbamylation and citrullination in HLA-DR4+ monozygotic twins discordant for rheumatoid arthritis.
    Clin Exp Immunol. 2016 Jun 17. doi: 10.1111/cei.12825.
    PubMed     Text format     Abstract available


  34. ALUNNO A, Carubbi F, Bistoni O, Caterbi S, et al
    Interleukin (IL)-17-producing pathogenic T lymphocytes co-express CD20 and are depleted by rituximab in primary Sjogren's syndrome: a pilot study.
    Clin Exp Immunol. 2016;184:284-92.
    PubMed     Text format     Abstract available


    May 2016
  35. SISTO M, Barca A, Lofrumento DD, Lisi S, et al
    Downstream activation of NF-kappaB in the EDA-A1/EDAR signalling in Sjogren's syndrome and its regulation by the ubiquitin-editing enzyme A20.
    Clin Exp Immunol. 2016;184:183-96.
    PubMed     Text format     Abstract available


  36. SORICE M, Buttari B, Capozzi A, Profumo E, et al
    Antibodies to age-beta2 glycoprotein I in patients with anti-phospholipid antibody syndrome.
    Clin Exp Immunol. 2016;184:174-82.
    PubMed     Text format     Abstract available


    March 2016
  37. VIERBOOM MP, Breedveld E, Kap YS, Mary C, et al
    Clinical efficacy of a new CD28-targeting antagonist of T cell co-stimulation in a non-human primate model of collagen-induced arthritis.
    Clin Exp Immunol. 2016;183:405-18.
    PubMed     Text format     Abstract available


  38. RUSCITTI P, Ciccia F, Cipriani P, Guggino G, et al
    The CD68(+)/H-ferritin(+) cells colonize the lymph nodes of the patients with adult onset Still's disease and are associated with increased extracellular level of H-ferritin in the same tissue: correlation with disease severity and implication for pat
    Clin Exp Immunol. 2016;183:397-404.
    PubMed     Text format     Abstract available


  39. PALMA ZOCHIO TOZZATO G, Taipeiro EF, Spadella MA, Marabini Filho P, et al
    Collagen-induced arthritis increases inducible nitric oxide synthase not only in aorta but also in the cardiac and renal microcirculation of mice.
    Clin Exp Immunol. 2016;183:341-9.
    PubMed     Text format     Abstract available


    January 2016
  40. SZABO K, Papp G, Szanto A, Tarr T, et al
    A comprehensive investigation on the distribution of circulating follicular T helper cells and B cell subsets in primary Sjogren's syndrome and systemic lupus erythematosus.
    Clin Exp Immunol. 2016;183:76-89.
    PubMed     Text format     Abstract available


    December 2015
  41. BOUTET MA, Bart G, Penhoat M, Amiaud J, et al
    Distinct Expression of IL-36alpha, beta, gamma, their antagonist IL-36Ra and IL-38 in psoriasis, rheumatoid arthritis and Crohn's disease.
    Clin Exp Immunol. 2015 Dec 23. doi: 10.1111/cei.12761.
    PubMed     Text format     Abstract available


  42. XING R, Jin Y, Sun L, Yang L, et al
    Interleukin-21 Induces Migration and Invasion of Fibroblast-like Synoviocytes from Patients with Rheumatoid Arthritis.
    Clin Exp Immunol. 2015 Dec 8. doi: 10.1111/cei.12751.
    PubMed     Text format     Abstract available


    November 2015
  43. KAGEYAMA G, Saegusa J, Irino Y, Tanaka S, et al
    Metabolomics analysis of saliva from patients with primary Sjogren's syndrome.
    Clin Exp Immunol. 2015;182:149-53.
    PubMed     Text format     Abstract available


    October 2015
  44. GOURZI VC, Kapsogeorgou EK, Kyriakidis NC, Tzioufas AG, et al
    Study of microRNAs (miRNAs) that are predicted to target the autoantigens Ro/SSA and La/SSB in primary Sjogren's Syndrome.
    Clin Exp Immunol. 2015;182:14-22.
    PubMed     Text format     Abstract available


  45. MULLER M, Herrath J, Malmstrom V
    IL-1R1 is expressed on both Helios(+) and Helios(-) FoxP3(+) CD4(+) T cells in the rheumatic joint.
    Clin Exp Immunol. 2015;182:90-100.
    PubMed     Text format     Abstract available


    September 2015
  46. AMBROSE N, Khan E, Ravindran R, Lightstone L, et al
    The exaggerated inflammatory response in Behcet's syndrome: identification of dysfunctional post-transcriptional regulation of the IFN-gamma/CXCL10 IP-10 pathway.
    Clin Exp Immunol. 2015;181:427-33.
    PubMed     Text format     Abstract available


  47. HULL DN, Williams RO, Pathan E, Alzabin S, et al
    Anti-tumour necrosis factor treatment increases circulating T helper type 17 cells similarly in different types of inflammatory arthritis.
    Clin Exp Immunol. 2015;181:401-6.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Rheumatoid Arthritis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: